In its Phase II, double-blind, multicenter, randomized dose-ranging study, 142 subjects with moderate-to-severe plaque psoriasis were randomized to placebo or 10, 23, 75 or 150 mg of ixekizumab.
A doctor may prescribe injectable treatments, such as methotrexate, TNF-alpha inhibitors, or interleukin inhibitors, for moderate to severe psoriasis when other treatments don’t work.
A 21-year-old Muslim, the product of a consanguineous marriage (paternal and maternal grandmothers were sisters) developed progressive papular and erythematosquamous rash over his abdomen on ...
Clinical and histological findings of palmoplantar pustulosis (PPP). (A) Multiple pustules and pustule-vesicles with ill-circumscribed erythemas on the right palm before secukinumab treatment; (B) A ...
Students’ Research Group ”Dermatology”, Faculty of Medicine, University of Opole, Opole, Poland Department of Dermatology, Regional Hospital, Institute of Medical Sciences, University of Opole, Opole, ...
IN THIS cohort study, genetic testing in 142 patients with palmoplantar keratoderma from 76 families identified 27 disease-causing variants across 13 genes, highlighting the role of genetics in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback